Formulary Search - PAD Formulary

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Asthma (Montelukast - Asthma)

Records returned : 11 (on 22 Dec 2024 at 08:05:41). Return to search results for ' Asthma '.

Drug

Indication

Status

Trust Alignment

Links

Restrictions/Comments

03.03.02

Montelukast

Asthma

Green

Formulations :

Chewable tablets
Sachets (granules)
Tablets

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

Important

https://www.gov.uk/drug-safety-update/montelukast-singulair-reminder-of-the-risk-of-neuropsychiatric-reactions

03.01.01

07.01.03

Salbutamol

Asthma

Green

Formulations :

Nebules

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

03.01.01

Terbutaline sulphate

Asthma

Blue

Formulations :

Nebules

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

Important

Primary Care may prescribe on recommendation from the Respiratory Care Team who will ensure that patients have had suitable training and trial of equipment to ensure safe use.

01.05.02

03.02.00

05.03.06

06.03.02

Budesonide

Asthma

Blue

Formulations :

Nebules

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

Important

Asthma prophylaxis. Primary Care may prescribe on recommendation from the Respiratory Care Team who will ensure that patients have had suitable training and trial of equipment to ensure safe use.

03.01.01

07.01.03

Salbutamol

Asthma

Red

Formulations :

Injection

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

Important

Unlicensed use in under 12 years of age.

03.01.01

Terbutaline sulphate

Asthma

Red

Formulations :

Injection

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

Important

Severe acute asthma

Dupilumab

Asthma

Red

Formulations :

Not Specified

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

Important

Specialised commissioned services only.

Sereflo Ciphaler (Salmeterol / Fluticasone) DPI

Asthma

N/A

Formulations :

Inhaler (dry powder)

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

NFD2

Campona Airmaster (Salmeterol / Fluticasone) DPI

Asthma

N/A

Formulations :

Inhaler (dry powder)

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

NFD2

03.01.01

07.01.03

Salbutamol

Asthma

Non Formulary

Formulations :

Modified release tablets
Oral solution
Tablets

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

03.01.03

Theophylline

Asthma

See narrative

Formulations :

Modified release tablets

ASPH

RSFT

SASH

SABP

Primary Care

Guidelines BNF SPC

Important

Place in therapy under review. Therapeutic drug monitoring required. Not recommended for primary care initiation without specialist advice.

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

ICB

Treatment commissioned by the ICB

BlueTeq

BlueTeq form to be completed

NICE

Traffic Light Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Black

Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.

Amber Star

Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)

See Below

Please add a description.

N/A

Please add a description.

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

Green - Black

Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.

See narrative

See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)

Do not initiate in new patients

These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)